PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2005 September; 6(3): E543–E551.
Published online 2005 October 27. doi:  10.1208/pt060368
PMCID: PMC2750402

Kinetic spectrophotometric method for the determination of ramipril in pharmaceutical formulations

Abstract

The objective of this research was to develop a kinetic spectrophotometric method for determination of ramipril in pure form and pharmaceutical formulations. The method was based on the reaction of carboxylic acid group of the drug with a mixture of potassium iodate (KIO3) and potassium iodide (KI) in aqueous medium at room temperature. The reaction is followed spectrophotometrically by measuring the increase in absorbance at 352 nm as a function of time. The initial-rate and fixed-time methods were adopted for constructing the calibration curves. Both the calibration curves were linear in the concentration range of 10.0–70.0 μg mL−1. The detection limits were 0.02μg mL−1 and 0.15-μg mL−1 for initial rate and fixed time methods, respectively. The proposed methods are validated statistically and through recovery studies. The point and interval hypothesis tests have been performed confirming that there is no significant difference between the proposed methods and the reference method. The experimental true bias of all samples is less than ±2%. The methods have been successfully applied to the determination of ramipril in tablets and capsules.

Keywords: initial-rate method, fixed-time method, ramipril, pharmaceutical formulations, spectrophotometry, validation

Full Text

The Full Text of this article is available as a PDF (183K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Martindale The Extra Pharmacopoeia. London: Royal Pharmaceutical Society; 2002:966–967.
2. Franz DN. Cardiovascular Drugs, 19th ed. In: Gennaro AR, editor. Remington: The Science and Practice of Pharmacy II. Pennsylvania: Mack Publishing Company; 1995. pp. 951–951.
3. Warner GT, Perry CM. Ramipril: a review of its use in the prevention of cardiovascular outcomes. Drugs. 2002;62:1381–1405. doi: 10.2165/00003495-200262090-00016. [PubMed] [Cross Ref]
4. British Pharmacopoeia. London: H. M. Stationery Office; 200:1331–1333.
5. Abdine HH, El-Yazbi FA, Shaalan RA, Blaih SM. Direct, differential solubility and compensatory-derivative spectrophotometric methods for resolving an subsequently determining binary mixtures of some antihypertensive drugs. STP Pharm Sci. 1999;9:587–591.
6. Salem H. Derivative spectrophotomtric determination of two component mixtures. Chin Pharm J. 1999;51:123–142.
7. Erk N. Ratio-spectra-zero-crossing derivative spectrophotometric determination of certain drugs in two component mixtures. Anal Lett. 1999;32:1371–1388. doi: 10.1080/00032719908542904. [Cross Ref]
8. Abdellatef HE, Ayad MM, Taha EA. Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu (II) J Pharm Biomed Anal. 1999;18:1021–1027. doi: 10.1016/S0731-7085(98)00113-7. [PubMed] [Cross Ref]
9. Ayad MM, Shalaby AA, Abdellatef HE, Hosny MM. Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation. J Pharm Biomed Anal. 2002;28:311–321. doi: 10.1016/S0731-7085(01)00595-7. [PubMed] [Cross Ref]
10. Salama FM, El-Sattar OIA, El-Aba Sawy NM, Fuad MM. Spectrophotometric determination of some ACE inhibitors through charge transfer complexes. Al Azhar J Pharm Sci. 2001;27:121–132.
11. Blaih SM, Abdine HH, El-Yazbi FA, Shaalan RA. Spectrophotometric determination of enalapril maleate and ramipril in dosage forms. Spectrosc Lett. 2000;33:91–102. doi: 10.1080/00387010009350061. [Cross Ref]
12. Al-Majed AA, Belal F, Al-Warthan AA. Spectrophotometric determination of ramipril (a novel ACE inhibitors) in dosage forms. Spectrosc Lett. 2001;34:211–220. doi: 10.1081/SL-100002010. [Cross Ref]
13. Al-Majed AA, Al-Zehouri J. Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablet and spiked human plasma. Farmaco. 2001;56:291–296. doi: 10.1016/S0014-827X(01)01070-9. [PubMed] [Cross Ref]
14. Hogan BL, Williams M, Idiculla A, Veysoglu T, Parente E. Development and validation of a chromatographic method for the determination of the related substances of ramipril in Altace capsule. J Pharm Biomed Anal. 2000;23:637–651. doi: 10.1016/S0731-7085(00)00342-3. [PubMed] [Cross Ref]
15. Sierra-Jimenez F, Sanchez-Pedreno C. The indicator system Hg2+-diphenylcarbazide. Anales real Soc Espan Fis y quim. 1958;54B:541–552.
16. Feigl F, editor. Preliminary (Exploratory) Tests. 6th ed. Amsterdam: Elsevier Publishing Company; 1960. pp. 117–118.
17. Popov AI, Deskin WA. Studies on the chemistry of halogens and of polyhalides, XV. Iodine halide complexes with acetonitrile. J Am Chem Soc. 1958;80:2976–2979. doi: 10.1021/ja01545a019. [Cross Ref]
18. Zhang J, Thickett D, Green L. Two tests for the detection of volatile organic acids and formaldehyde. JAIC. 1994;33:47–53.
19. Morelli B. Spectrophotometric assay of chloramphenicol and some derivatives in the pure form and in formulations. J Pharm Biomed Anal. 1987;5:577–583. doi: 10.1016/0731-7085(87)80068-7. [PubMed] [Cross Ref]
20. Morelli B. “Zero crossing”: derivative spectrophotometric determination of mixtures of cephapirin sodium and cefuroxime sodium in pure form and in injections. Analyst. 1988;113:1077–1081. doi: 10.1039/an9881301077. [PubMed] [Cross Ref]
21. Miller JN. Basic statistical method for analytical chemistry: Part II. Calibration and regression methods. Analyst. 1991;116:3–14. doi: 10.1039/an9911600003. [Cross Ref]
22. Nallimov VV. The Application of Mathematical Statistics to Chemical Analysis. Oxford: Pergamon Press; 1963. pp. 189–189.
23. Christian GD, editor. Data Handling. 5th ed. Singapore: John Wiley and Sons, Inc; 1994. pp. 35–37.
24. CRC Handbook of Chemistry and Physics. 63rd ed. Boca Raton, Florida: CRC Press, Inc; 1982. pp. C518–C518.
25. Hartmann C, Smeyers-Verbeke J, Pinninckx W, Heyden YV, Vankeerberghen P, Massart DL. Reappraisal of hypothesis testing for method validation: detection of systematic error by comparing the means of two methods or of two laboratories. Anal Chem. 1995;67:4491–4499. doi: 10.1021/ac00120a011. [Cross Ref]
26. Canada Health Protection Branch.Drugs Directorate Guidelines. Acceptable methods, Ministry of National Health and Welfare, Draft. 1992.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists